Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01986660 · ClinicalTrials.gov registry record · Phase 1
Open-Label, Maximum-Dose Pharmacokinetic Study of 7.5% Ibuprofen Cream (SST-0225) in Healthy Adults
A Phase 1 study, sponsored by Strategic Science & Technologies.
- Completed
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
NCT01986660: Completed Phase 1 study, sponsored by Strategic Science & Technologies.
NCT01986660 is a Phase 1 study that has completed, run by Strategic Science & Technologies. The registered enrollment target is 14 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01986660, a Phase 1 study, has completed, sponsored by Strategic Science & Technologies.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate how Ibuprofen Cream (SST-0225) is absorbed and eliminated by the body under defined maximum dosing conditions and to evaluate the safety under these conditions.
Interventions
- DRUG Ibuprofen Cream (SST-0225)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2013-10 |
| Est. Completion | 2013-10 |
| Phase | Phase 1 |
What the finished NCT01986660 record still lists
NCT01986660 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 1 intervention - of which Ibuprofen Cream (SST-0225) is the first listed.
NCT01986660 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01986660 about?
NCT01986660 is a clinical study titled "Open-Label, Maximum-Dose Pharmacokinetic Study of 7.5% Ibuprofen Cream (SST-0225) in Healthy Adults". The purpose of this study is to evaluate how Ibuprofen Cream (SST-0225) is absorbed and eliminated by the body under defined maximum dosing conditions and to evaluate the safety under these conditions.
What is the current status of trial NCT01986660?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2013-10. Estimated completion is 2013-10.
What interventions are being tested in trial NCT01986660?
The interventions under investigation include: Ibuprofen Cream (SST-0225) (DRUG).
Who is sponsoring clinical trial NCT01986660?
This trial is sponsored by Strategic Science & Technologies, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01986660's enrollment target sits among peer trials
14 1844th of 2000 higher than 154 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia